Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system

Molecular Pharmacology

Volumn 62, Issue 1, 2002, Pages 1-6

  Kimchi Sarfaty, Chava ^a   Gribar, John J ^a   Gottesman, Michael M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4 DIFLUORO 5,7 DIMETHYL 4 BORA 3A,4A DIAZA S INDACENE 3 PENTANOIC ACID; BISANTRENE; CALCEIN; DAUNORUBICIN; FLUORESCENT DYE; FORSKOLIN; GLYCOPROTEIN P; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1; PRAZOSIN; UNCLASSIFIED DRUG; VERAPAMIL; VINBLASTINE;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME SPECIFICITY; FLUORESCENCE; GENE EXPRESSION SYSTEM; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VACCINIA VIRUS; WESTERN BLOTTING;

FLUORESCENT DYES; GENE EXPRESSION; GENETIC VECTORS; HELA CELLS; HUMANS; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; PROTEIN BIOSYNTHESIS; TIME FACTORS; TRANSFECTION; VACCINIA VIRUS;

EID: 0036082545     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.1.1     Document Type: Article

References (34)

1. Biochemical, cellular and pharmacological aspects of the multidrug transporter
2. MDR1 pharmacogenetics: Frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
3. HMG-CoA reductase inhibitors and P-glycoprotein modulation
4. The multidrug resistance protein family
5. A family of drug transporters: The multidrug resistance-associated proteins
6. Pharmacogenetics of the human drug-transporter gene MDR1: Impact of polymorphisms on pharmacotherapy
7. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
8. A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans
9. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
10. A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein
11. Propagation of cell cultures and vaccinia virus stocks
12. Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells
13. Mechanisms of cancer drug resistance
14. Genetic analysis of the multidrug transporter
15. Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system
16. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein
17. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells
18. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P- glycoprotein expression and activity in vivo
19. Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system
20. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects
21. ABC drug transporters: Hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
22. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
23. Identification of functionally variant MDR1 alleles among European Americans and African Americans
24. Rapid and efficient site-specific mutagenesis without phenotypic selection
25. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter
26. P-glycoprotein and bioavailability-implication of polymorphism
27. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein
28. Genetic polymorphism in MDR-1: A tool for examining allelic expression in normal cells, unselected and drug-selected cell lines and human tumors
29. Recombinant vaccinia virus vectors for functional expression of P- glycoprotein in mammalian cells
30. Frequency of C3435T polymorphism of MDR1 gene in African people
31. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
32. Cellular localization of the multidrug-resistance gene product P- glycoprotein in normal human tissues
33. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein
34. A polymorphic HindIII site within the human multidrug resistance gene 1 (MDR1)